January 29, 2018

Abeona Receives FDA Regenerative Medicine Advanced Therapy Designation

Abeona Therapeutics receives the Regenerative Medicine Advanced Therapy designation for its cell therapy for patients with recessive dystrophic epidermolysis bullosa.

Read More  >